Specialty Urology
-
Featured
Active Surveillance for Prostate Cancer
In this video, Keyan Salari, MD, PhD, discusses his team's work to identify the features of seemingly indolent prostate cancers that actually make them more aggressive.
-
Featured
Mass General Offers Novel, Kidney-saving Urothelial Cancer Treatment
Mitomycin chemoablation with a mitomycin gel, a novel treatment offered in the Department of Urology at Massachusetts General Hospital, can avoid the need for surgical removal of the kidney and ureter in patients with upper tract urothelial cancer.
-
Auto-Contouring Model Performs Well for Prostate Cancer Patients Who Receive Radiopaque Hydrogel Spacer
Yi Wang, PhD, Jason A. Efstathiou, MD, DPhil, and colleagues have validated a CT-based deep learning model that provides automated contouring when planning radiation therapy for prostate cancer patients who receive the SpaceOAR Vue rectal spacer.
-
Review: Checkpoint Inhibitors and Other Immunotherapies in Urologic Cancer
Aleksandra Walasek, MD, and Dimitar V. Zlatev, MD, discuss progress in immunotherapies for urologic cancers, showing checkpoint inhibitors are often first-line therapy, combination regimens are improving outcomes, and antibody–drug conjugates are becoming new options for dual-refractory bladder cancer.
-
Combined Standard and Targeted Transperineal Biopsies Advised for Patients With Prostate Lesion on Multiparametric MRI
Massachusetts General Hospital researchers recommend patients who have a prostate lesion on multiparametric MRI should undergo both standard and targeted biopsy using the transperineal approach, as that resulted in a Gleason grade most concordant with the results from radical prostatectomy specimens.
-
Primary Prostate Cancer Establishes a Suppressive Immune Microenvironment
Through careful unraveling of the cellular and molecular landscape of prostate cancer, Massachusetts General Hospital researchers observed a highly immune-suppressive tumor microenvironment with a pattern of angiogenic gene expression, findings that will help identify targets amenable to therapeutic interventions.
Urology Contributors
-
Adam Scott Feldman, MD, MPH
Director, Combined Harvard Urologic Oncology Fellowship, Director of Research and Urologic Oncologist, Department of Urology, Massachusetts General Hospital
Recent Article
Combined Standard and Targeted Transperineal Biopsies Advised for Patients With Prostate Lesion on Multiparametric MRI
-
Ajay Nehra, MBBS
Director of Men's Health and Male Reconstructive Surgery, Senior Urologic Surgeon
Recent Article
Establishing Guidelines for Peyronie's Disease
-
Brian Howard Eisner, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
Recent Article
Diabetes Not a Risk Factor for Septic Shock Among Patients With Ureteral Stone and UTI
-
Dianne E. Sacco, MD
Co-Director, Kidney Stone Program, Assistant Professor of Surgery, Harvard Medical School
-
Douglas Middleton Dahl, MD
Chief, Division of Urologic Oncology, Director of Robotic Surgery, Massachusetts General Hospital, Associate Professor of Surgery (Urology), Harvard Medical School
Recent Article
Combined Standard and Targeted Transperineal Biopsies Advised for Patients With Prostate Lesion on Multiparametric MRI
-
-
Keyan Salari, MD, PhD
Urologic Surgeon, Department of Urology, Massachusetts General Hospital, Urologic Oncologist, Mass General Cancer Center, Director, Prostate Cancer Genetics Program
Recent Article
Review: Biomarkers in Testicular Cancer
-
Matthew F. Wszolek, MD
Chair of Quality and Safety, Department of Urology, Massachusetts General Hospital, Urological Oncologist, Mass General Cancer Center, Instructor in Surgery, Harvard Medical School
Recent Article
Mortality Related to Surgical Staplers and Clip Appliers Is Increasing
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.